Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet

Overview of attention for article published in Frontiers in oncology, July 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 54 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY COMPRISING A RAF INHIBITOR AND TRAMETINIB

Grant EP-3618875-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.